These results provide a novel pharmacological approach to promote lipid metabolism and improve insulin responsiveness in myotubes, which may be of therapeutic importance for obesity and type 2 diabetes. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.